MedPath

A clinical trial on ayurvedic therapy in delayed and scanty menses

Phase 2
Conditions
Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Registration Number
CTRI/2022/06/043068
Lead Sponsor
ational Institute of AyurvedaJaipur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age of patient between 20-35 years, Married/unmarried patients suffering from any two of the following cardinal symptoms of ArtavaKshaya:

1-Yathochitakalaadarshanam -if the interval between 2 menstrual cycles exceeds more than 35 days.

2- Alpartavam â?? a) Duration of bleeding <3 days â?? score less than 25

in PBAC (Pictorial blood loss assessment chart).

b) Decrease in quantity of bleeding -score less than 20 in PBAC (Pictorial blood loss assessment chart).

3- YoniVedana - Pain during menstruation in internal genital organs.

Exclusion Criteria

1-Pregnancy, labor or breastfeeding within the past 3 months. 2-History of intake of oral contraceptive or ovulation inducing agent within the past 3 months. 3- Established endocrine disorders. 4- Interval between 2 consecutive menstrual cycles is more than 6 months. 5- Oligomenorrhea with hypermenorrhea. 6- Patient suffering from any uterine or pelvic pathology. 7- Patient with any malignancy or anatomical defect. 8- Patient suffering from any severe systemic disorders. 9-Intake of psychoactive drugs or antiepileptic drugs (valproic acid).10- Patient vaccinated against covid19 within last3 months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in classical triad of ArtavaKshaya assessed on the basis of Pictorial blood loss assessment chart and Visual Analogue Scale (VAS).Timepoint: Base line, follow up in 15 days
Secondary Outcome Measures
NameTimeMethod
1- Safety of drugs assessed through LFT and RFT. <br/ ><br>2- Improvement in quality of lifeassessed through SF-36 questionnaire.Timepoint: 60 days
© Copyright 2025. All Rights Reserved by MedPath